bf/NASDAQ:CNTX_icon.jpeg

NASDAQ:CNTX

Context Therapeutics Inc.

  • Stock

USD

Last Close

1.39

28/03 20:00

Market Cap

15.49M

Beta: -

Volume Today

55.95K

Avg: 99.97K

PE Ratio

−0.80

PFCF: −0.90

  • industry

    Biotechnology
  • exchange

    NASDAQ Capital Market
  • website

    www.contexttherapeutics.com
  • ipo date

    Jul 28, 2021
  • full time employees

    9
  • currency

    USD

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to r...Show More

Earnings

Earnings per Share (Estimate*)

-0.50.511.52020-03-312020-12-312021-12-022022-08-112023-05-102024-03-27

Revenue (Estimate*)

0.000.000.010.010.012020-03-312020-12-312021-12-022022-08-112023-05-102024-03-27

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.